Press Release
Category Added in a WPeMatico Campaign
-
The Growing Demand for Phone Opening Disassembly Tool and Screen Opening Tool Kit in the Repair Industry
Among the most essential tools in this space are the phone Opening Disassembly Tool and Screen Opening Tool Kit. These…
Read More » -
Keeper Security Expands Privileged Access Management Browser Isolation to Support Advanced Web Browsing Workflows
New capabilities remove usability barriers by enabling multi-tab browsing, secure file upload/download and KeeperAI threat detection within privileged vault sessions…
Read More » -
Keeper Security Expands Privileged Access Management Browser Isolation to Support Advanced Web Browsing Workflows
New capabilities remove usability barriers by enabling multi-tab browsing, secure file upload/download and KeeperAI threat detection within privileged vault sessions…
Read More » -
Keeper Security Expands Privileged Access Management Browser Isolation to Support Advanced Web Browsing Workflows
New capabilities remove usability barriers by enabling multi-tab browsing, secure file upload/download and KeeperAI threat detection within privileged vault sessions…
Read More » -
Phemex TradFi Crude Oil Trading Surges 300% as Ceasefire Volatility Sparks Record Demand
APIA, Samoa, April 9, 2026 /PRNewswire/ — Phemex, a user-first crypto exchange, reported that crude oil perpetual futures volume on its…
Read More » -
Phemex TradFi Crude Oil Trading Surges 300% as Ceasefire Volatility Sparks Record Demand
APIA, Samoa, April 9, 2026 /PRNewswire/ — Phemex, a user-first crypto exchange, reported that crude oil perpetual futures volume on its…
Read More » -
Phemex TradFi Crude Oil Trading Surges 300% as Ceasefire Volatility Sparks Record Demand
APIA, Samoa, April 9, 2026 /PRNewswire/ — Phemex, a user-first crypto exchange, reported that crude oil perpetual futures volume on its…
Read More » -
AllRock Bio Doses First Patients in Phase 2a Trial of ROC-101 for Pulmonary Hypertension
Phase 2a ROCSTAR study is evaluating ROC-101, a potential first-in-class oral pan-ROCK inhibitor, in PAH and ILD-PH patients Clinical trial…
Read More » -
AllRock Bio Doses First Patients in Phase 2a Trial of ROC-101 for Pulmonary Hypertension
Phase 2a ROCSTAR study is evaluating ROC-101, a potential first-in-class oral pan-ROCK inhibitor, in PAH and ILD-PH patients Clinical trial…
Read More » -
AllRock Bio Doses First Patients in Phase 2a Trial of ROC-101 for Pulmonary Hypertension
Phase 2a ROCSTAR study is evaluating ROC-101, a potential first-in-class oral pan-ROCK inhibitor, in PAH and ILD-PH patients Clinical trial…
Read More »